NCT03757195

Unknown

Augmentation of Maxillary Horizontal And Vertical Bone Defic...

Cairo University Source

Compare

Other study identifiers

Sponsor study identifier

CEBC-CU-2017-11-16

Study Type

interventional

Estimated enrollment

28

Locations

1 country

Sites

2

Timeline

Study Start

November 15, 2018

Actual (reported)

Primary Completion

July 29, 2020

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Study Completion

October 25, 2020

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Brief Summary

A new technique of grafting introduce called Mineralized plasmatic matrix. This technique can be used in grafting in anterior zone giving a good results and bone substitution occur using allograft or xenograft. The bone graft have a good consistency when it mixed with plasma give easy application, strength and stability of the graft. Also plasma rich with CGF (Cellular growth factors).

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: unknown
Estimated enrollment: 28 participants
Study completion date: October 25, 2020
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Listed locations: 1 countries · 2 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

First Submitted
November 27, 2017
Actual (reported)
Study Start
November 15, 2018
Actual (reported)
First Posted
November 28, 2018
Actual (reported)
Primary Completion
July 29, 2020
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
October 25, 2020
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.

Last Updated: November 28, 2018
Status Verified: November 2018
Last Update Submitted: November 27, 2018

Conditions

Alveolar Ridge Abnormality of Maxilla

Keywords

Mineralized plasmatic matrixsticky boneplasmaautogeous fibrin glue

Outcome Measures

Primary Outcomes (1)

amount of bone loss
amount of bone loss after xenograft by CBCT
change from baseline at 6 months

Study Arms (1)

augmentation by xenograft

EXPERIMENTAL

xenograft mixed with plasma extracted from blood

Procedure: Augmentation

Interventions

AugmentationProcedure

combination product

augmentation by xenograft

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age20 Years - 40 Years

Sexall

Healthy VolunteersYes

Age GroupsAdult (18-64)

You may qualify if:

Age: from 20 to 40 years old
no history of previous grafting.

Sponsors & Collaborators

Cairo University
Otherlead

Study Sites (2)

Cairo Univerisity

Cairo, Egypt

RECRUITING

Hany M Ahmed, BDSCONTACT00201091971228 hanyyusf4@gmail.com

Cairo University

Cairo, Egypt

NOT_YET_RECRUITING

Tarek I. Abdallah, P.H.DCONTACT

Hany M. Ahmed, B.D.SPRINCIPAL INVESTIGATOR

Study Officials

Tarek I. Abdallah, P.H.D
Cairo University
STUDY DIRECTOR

Central Study Contacts

Hany M Ahmed, B.D.S

CONTACT

00201091971228 hanyyusf4@gmail.com

Tarek I Abdallah, P.H.D

CONTACT

01282931864

Study Design

Study Type: interventional
Phase: not applicable
Allocation: NA
Masking: NONE
Purpose: TREATMENT
Intervention Model: SINGLE GROUP
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Resident of Oral Surgery in Nahda University

Study Record Dates

First Submitted

November 27, 2017

First Posted

November 28, 2018

Study Start

November 15, 2018

Actual (reported)

Primary Completion

July 29, 2020

Estimated (date passed)

no History of previous implant placement

Medically Free e.g no debilitating diseases

You may not qualify if:

Smoker patients.
Alcoholic patients
Pregnant.
Drug Abusers.
Hypertensive , Diabetic, having Problems or disease in Kidney and/or liver.
Thyroid Disease.
Problem in Vit.D absorption or in calcitonin hormone secretion.
History of blood transfusion or donating blood less than 4 months.
Patient under Corticosteroid therapy.
Neurologicaly unstable patients.
History of radiotherapy or chemo-therapy.
Patient undergo Spect C.T Scan less than 4 Months .

Contact the study team to confirm eligibility.

t_ghareeb@hotmail.com

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Study Completion

October 25, 2020

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Last Updated

November 28, 2018

Record last verified: 2018-11

Data Sharing

IPD Sharing: Will not share

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT03757195
Data provider: ClinicalTrials.gov
Source updated: 2018-11-28
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:39:47 UTC

Locations

EG(2)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

Study Start

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Study Arms (1)

augmentation by xenograft

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (2)

Study Officials

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations